STS and colorectal carcinoma: By examining key estrogen-metabolizing enzymes in matched normal and cancerous human colorectal tissue and then translating the findings to in vitro and in vivo systems, we have demonstrated, to the best of our knowledge for the first time, that CRC exhibits dysregulated estrogen metabolism with STS activity and estrogen reductase pathways elevated in CRC.